MRI signal suppression agents, compositions, and methods
US10814019B2 · kind B2 · utility
0Cited by
4References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 2015 |
| Grant date | Oct 27, 2020 |
| Priority date | — |
| Expiry date | May 31, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01R33/5607
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
To solve the problem of differentiating veins from lymphatics in MRI images, among other uses, the disclosed embodiments relate to compositions, kits, systems, and methods that include an MRI contrast agent and an MRI suppression agent that is also a blood pool agent. Using appropriate MRI techniques, the MRI suppression agent will suppress signal in its location, while signal enhanced by the MRI contrast agent in other locations will not be suppressed. The result is a clarified MRI image with only non-vascular regions enhanced.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.